The webinar showed two engaged, clear and committed executives/directors/shareholders.
That's aside from great results.
They answered the questions incredibly well.
There were a significant number of fund managers and brokers on the call (I googled the attendees listed during the call).
Pharmaceutical manufacturing is clearly on the agenda.
The share price has been stubbornly stuck in a tight range for ages though. Including today.
Add to My Watchlist
What is My Watchlist?